Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching. 2015

Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
Department of Psychiatry, Juntendo University, School of Medicine, Tokyo, Japan.

BACKGROUND The relationship between psychomotor agitation in unipolar depression and mood-switching from depression to manic, hypomanic and mixed states has been controversial. We investigated the future risk of initial mood-switching as a function of psychomotor agitation in unipolar depression. METHODS We identified 189 participants diagnosed with major depressive disorder (MDD). We divided all patients with MDD into two categories (1) agitated patients (n=74), and (2) non-agitated patients (n=115). These groups were prospectively followed and compared by time to mood-switching. Kaplan-Meier survival curves, log-rank test for trend for survivor functions, and Cox proportional hazard ratio estimates for a multivariate model were conducted to examine the risk of mood-switching by psychomotor agitation. RESULTS During follow-up, mood-switching occurred in 20.3% of the agitated patients and 7.0% of the non-agitated patients. In the Kaplan-Meier survival estimates for time to incidence of mood-switching with agitated or non-agitated patients, the cumulative probability of developing mood-switching for agitated patients was higher than those for non-agitated patients (log-rank test: χ(2)=7.148, df=1, p=0.008). Survival analysis was also performed using Cox proportional hazards regression within a multivariate model. The agitation remained significantly associated with incidence of mood-switching (HR=2.98, 95% CI: 1.18-7.51). CONCLUSIONS We did not make a clear distinction between antidepressant-induced mood-switching and spontaneous switching. CONCLUSIONS The main finding demonstrated that MDD patients with agitation were nearly threefold as likely to experience mood-switching, suggesting that psychomotor agitation in MDD may be related to an indicator of bipolarity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011595 Psychomotor Agitation A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions. Agitation, Psychomotor,Akathisia,Excitement, Psychomotor,Restlessness,Psychomotor Hyperactivity,Psychomotor Restlessness,Hyperactivity, Psychomotor,Psychomotor Excitement,Restlessness, Psychomotor
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
October 2019, European archives of psychiatry and clinical neuroscience,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
August 2006, Emotion (Washington, D.C.),
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
May 2014, Medical hypotheses,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
May 2008, Cortex; a journal devoted to the study of the nervous system and behavior,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
January 2009, Neuropsychobiology,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
April 2023, FP essentials,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
May 2008, Evidence-based mental health,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
January 2015, Frontiers in psychiatry,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
February 2009, European archives of psychiatry and clinical neuroscience,
Takao Iwanami, and Hitoshi Maeshima, and Hajime Baba, and Emi Satomura, and Yuki Namekawa, and Takahisa Shimano, and Toshihito Suzuki, and Heii Arai
October 2019, European archives of psychiatry and clinical neuroscience,
Copied contents to your clipboard!